Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,285,340
-
Total 13F shares
-
46,847,791
-
Share change
-
+4,599,588
-
Total reported value
-
$657,293,219
-
Put/Call ratio
-
134%
-
Price per share
-
$14.03
-
Number of holders
-
179
-
Value change
-
+$62,276,957
-
Number of buys
-
107
-
Number of sells
-
74
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q3 2015
As of 30 Sep 2015,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by
179 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,847,791 shares.
The largest 10 holders included
NEA Management Company, LLC, BlackRock Fund Advisors, STATE STREET CORP, Invesco Ltd., Ranger Investment Management, L.P., Apex Capital Management, VANGUARD GROUP INC, GLENMEDE TRUST CO NA, Murphy Michael R, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
179
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.